Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.
It is well known that epilepsy, antiepileptic drugs (AEDs), and the reproductive system have complex interactions. Fertility is lower in both men and women with epilepsy than in the general population. Moreover, reproductive endocrine disorders are more common among patients with epilepsy than among the population in general. These disorders have been attributed both to epilepsy itself and to use of AEDs. The use of the liver enzyme-inducing AEDs phenobarbital, phenytoin and carbamazepine increases serum sex hormone-binding globulin (SHBG) concentrations in both men and women with epilepsy. Over time, the increase in serum SHBG levels leads to diminished bioactivity of testosterone and estradiol, which may result in diminished potency in men and menstrual disorders in some women, and thus to reduced fertility. Liver enzyme-inducing AEDs also reduce the efficacy of oral contraceptives. Valproic acid medication may have effects on serum androgen concentrations and it reduces serum follicle stimulating hormone levels in men with epilepsy. However, the clinical significance of valproic acid-related reproductive endocrine changes in men is unknown. On the other hand, in women, use of valproic acid appears to be associated with a frequent occurrence of reproductive endocrine disorders characterised by polycystic changes in the ovaries, high serum testosterone concentrations (hyperandrogenism) and menstrual disorders. These disorders are especially common among women who have gained weight during valproic acid treatment. There are some discrepancies regarding the reported occurrence of reproductive endocrine disorders in women taking valproic acid for epilepsy. However, most studies also including patients receiving valproic acid for other reasons than epilepsy, and studies in different non-epileptic animal models, have shown an association between valproic acid medication and hyperandrogenism and related reproductive endocrine disorders. From a practical point of view, the length of the menstrual cycles and bodyweight should be monitored in women with epilepsy after commencement of treatment with valproic acid. A serum testosterone assay is helpful in following the possible biochemical endocrine changes. Ultrasonography of the ovaries (preferably transvaginal) is indicated if clinical assessment and serum testosterone measurement imply that there is a clinically significant valproic acid-related reproductive endocrine problem. That would be the case if the menstrual cycles were irregular or prolonged (usually >35 days) and serum testosterone levels elevated, especially with associated weight gain. The endocrine effects of the new AEDs have not been widely studied. However, it seems they may offer an alternative if reproductive endocrine problems emerge during treatment with the older AEDs.
Isojärvi
Jouko I T
JI
Department of Neurology, University of Oulu, Oulu, Finland. jouko.i.isojarvi@gsk.com
Taubøll
Erik
E
Herzog
Andrew G
AG
D000927:Anticonvulsants / Q000009:adverse effects*; D004702:Endocrine Glands / Q000187:drug effects*; D004827:Epilepsy / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects*
D000927:Anticonvulsants
Reprod Toxicol. 2002 May-Jun;16(3):319-25
12128106
Neurology. 2001 Jan 9;56(1):31-6
11148232
Ann Neurol. 2003 Nov;54(5):625-37
14595652
Scott Med J. 1985 Apr;30(2):101-5
3925547
Epilepsia. 2001 Mar;42(3):305-10
11442144
Epilepsia. 1994 Jul-Aug;35(4):750-6
8082617
Epilepsia. 2004 Jul;45(7):764-8
15230699
Toxicology. 1990 Aug;63(2):137-55
2119078
Epilepsia. 1989 Jan-Feb;30(1):50-6
2492224
Epilepsia. 1988 Sep-Oct;29(5):612-9
3044776
Clin Endocrinol (Oxf). 1978 Mar;8(3):185-91
346267
J Clin Endocrinol Metab. 1986 Jul;63(1):243-5
2940256
Reprod Toxicol. 2002 Nov-Dec;16(6):767-73
12401504
Metabolism. 1992 Jun;41(6):666-70
1640853
J Clin Endocrinol Metab. 1961 Mar;21:252-62
13731058
Epilepsia. 1998 Feb;39(2):140-9
9577993
Neurology. 2001 Aug 14;57(3):440-4
11502910
Epilepsia. 1995 Aug;36(8):810-6
7635100
Epilepsia. 1989 Jul-Aug;30(4):446-52
2526730
Epilepsia. 1992 Nov-Dec;33(6):1149-52
1464278
Lancet. 1956 Dec 15;271(6955):1235-7
13386215
Seizure. 2000 Oct;9(7):480-5
11034872
Neurology. 1993 Oct;43(10):1907-10
8413946
J Steroid Biochem Mol Biol. 1991;40(4-6):735-53
1958572
N Engl J Med. 1985 Jul 18;313(3):145-51
3925335
Epilepsia. 1980 Jun;21(3):261-71
7189711
Epilepsia. 1994 Jan-Feb;35(1):136-40
8112236
J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):121-5
12122167
Epilepsia. 2001 Mar;42(3):295-304
11442143
J Neurol. 2002 Jul;249(7):835-41
12140666
Epilepsy Res. 2003 May;54(2-3):189-99
12837570
J Clin Psychiatry. 2002 Apr;63(4):322-30
12000206
Epilepsia. 1993 Mar-Apr;34(2):220-7
8453929
Epilepsia. 1985;26 Suppl 1:S40-51
3158512
Epilepsia. 1999 Apr;40(4):520-1
10219283
J Endocrinol Invest. 1987 Feb;10(1):27-31
3110250
J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):824-6
6413659
Clin Endocrinol (Oxf). 1993 Jul;39(1):1-16
8348699
J Clin Endocrinol Metab. 2001 Jul;86(7):2950-6
11443149
Epilepsia. 1978 Aug;19(4):323-36
81129
Epilepsia. 1994 Nov-Dec;35(6):1217-20
7988514
Arch Neurol. 1986 Apr;43(4):341-6
2937394
Clin Endocrinol (Oxf). 1984 Feb;20(2):163-8
6424973
Ann Neurol. 2002 Dec;52(6):704-11
12447923
J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):913-4
569688
Ann Neurol. 1999 Apr;45(4):444-50
10211468
Epilepsia. 1999 Oct;40(10):1370-7
10528931
Clin Endocrinol (Oxf). 1993 Dec;39(6):623-32
8287579
Epilepsia. 1995 Jul;36(7):676-81
7555984
Epilepsia. 1984 Dec;25(6):690-4
6439551
Epilepsy Res. 2000 Sep;41(2):163-7
10940617
Endocr Rev. 1984 Winter;5(1):76-127
6142819
Neuropsychobiology. 1994;30(1):29-36
7969856
Drugs. 1992 Jun;43(6):873-88
1379159
J Clin Endocrinol Metab. 1992 Jun;74(6):1355-60
1375600
Scand J Clin Lab Invest. 1978 Dec;38(8):731-6
105401
Eur J Neurol. 2003 Sep;10(5):501-6
12940829
Epilepsia. 1995 Apr;36(4):366-70
7607115
Br Med J. 1977 Oct 8;2(6092):934-5
562217
Neurology. 2004 Jan 27;62(2):247-53
14745062
J Endocrinol. 1997 May;153(2):307-12
9166121
Br J Clin Pharmacol. 1984 Mar;17(3):347-51
6231939
Epilepsia. 2003 Aug;44(8):1014-21
12887432
Clin Neuropharmacol. 1998 Jan-Feb;21(1):52-8
9579286
Neurology. 1999;53(4 Suppl 1):S42-8
10487515
Epilepsia. 1988 Jul-Aug;29(4):468-75
3134193
N Engl J Med. 1993 Nov 4;329(19):1383-8
8413434
Arch Neurol. 1986 Apr;43(4):347-50
3082313
Epilepsy Res. 1991 Jul;9(2):139-44
1794350
Acta Neurol Scand. 1981 Feb;63(2):111-21
6782820
Ann Neurol. 1986 Dec;20(6):716-22
3101579
Br J Clin Pharmacol. 1991 Jan;31(1):65-71
2015172
Eur J Clin Pharmacol. 1995;47(5):461-4
7720770
Epilepsy Behav. 2003 Aug;4(4):407-13
12899861
Epilepsia. 1999 Feb;40(2):197-204
9952267
Biol Psychiatry. 1997 Oct 1;42(7):617-24
9376458
Arch Neurol. 1990 Jun;47(6):670-6
2135734
Neurology. 2001 Jan 23;56(2):172-7
11160951
Dtsch Tierarztl Wochenschr. 1999 Mar;106(3):110-3
10220947
Acta Neurol Scand. 1984 Aug;70(2):65-9
6435386
Ann Neurol. 1998 Apr;43(4):446-51
9546324
Eur J Clin Pharmacol. 1990;39(2):187-8
2253672
Eur J Pharmacol. 1990 May 31;181(1-2):151-5
2167228
Seizure. 2003 Dec;12(8):529-33
14630488
Ann Neurol. 2002 May;51(5):559-66
12112101
Ann Neurol. 1996 May;39(5):579-84
8619542
Br J Clin Pharmacol. 1984 Sep;18(3):401-10
6435654
Epilepsia. 1991 Jul-Aug;32(4):550-3
1868812
Arch Neurol. 1989 Nov;46(11):1175-8
2510703
Epilepsia. 2001 Mar;42(3):311-5
11442145
Seizure. 2001 Dec;10(8):559-65
11792156
Biochem Pharmacol. 1993 Jul 20;46(2):199-204
8347141
J Endocrinol Invest. 1997 Oct;20(9):519-26
9413805
Am J Med. 2001 Sep;111(4):290-6
11566460
Seizure. 2003 Sep;12(6):323-9
12915077
Br Med J (Clin Res Ed). 1982 Jan 9;284(6309):85-6
6797670
Epilepsia. 1999 Jun;40(6):783-7
10368079
Exp Toxicol Pathol. 2001 Feb;52(6):545-52
11256757
Epilepsia. 1996 Sep;37(9):833-40
8814095
Endocr Rev. 1992 Nov;13(4):641-69
1281087
Epilepsia. 1984 Feb;25(1):46-52
6319114
Epilepsia. 1988 Nov-Dec;29(6):781-6
3191895
Neurology. 2004 Feb 10;62(3):445-50
14872028
J Clin Endocrinol Metab. 2001 Jul;86(7):2946-9
11443148
Epilepsia. 1992 Jan-Feb;33(1):149-53
1733750
Neurology. 2000 Feb 22;54(4):973-5
10690996
Epilepsia. 1990 Jul-Aug;31(4):438-45
2142450
Lancet. 1998 Dec 19-26;352(9145):1970-3
9872246
J Neurol Neurosurg Psychiatry. 1982 Sep;45(9):844-6
6813428
Br J Clin Pharmacol. 1990 Dec;30(6):892-6
2126946
Br Med J (Clin Res Ed). 1981 Aug 29;283(6291):577-81
6790086
Epilepsia. 1986 Nov-Dec;27(6):746-52
3780612